ADVERTISEMENT

Conference Report

ESMO 2022 – Highlights on breast cancer, early-stage disease

Cristina Ferrario — Agenzia Zoe   |   13 September 2022

Takeaway

  • Nice confirmatory data were presented supporting clinical practice decisions.
  • An active search for biomarkers is ongoing, to refine patient selection and make adequate therapeutic decisions.

 

Tackling the hard challenge to pack all the results from the early breast cancer (eBC) track in a 20-minute presentation, Ana Bosh, Skåne...

          

November Challenge

Ends in 1d 5h
left
right

Topic Challenges

left
right